カテゴリー： Market Monitor Global, 世界, 医療/バイオ

眼瞼痙攣治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Blepharospasm Therapeutic Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5721）◆商品コード：MMG23JU5721
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Blepharospasm Therapeutic Market 調査レポートは次の情報を含め、グローバルにおけるの眼瞼痙攣治療薬市場規模と予測を収録しています。・世界の眼瞼痙攣治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の眼瞼痙攣治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の眼瞼痙攣治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗コリン薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

眼瞼痙攣治療薬のグローバル主要企業は、Pfizer Inc.、 Novartis AG、 Sanofi、 Merck and Co.、 Aspen Holdings、 Boston Scientific Corporation、 Ipsen Pharma、 Revance Therapeutics, Inc.、 Merz Pharma、 Allerganなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、眼瞼痙攣治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の眼瞼痙攣治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の眼瞼痙攣治療薬市場：タイプ別市場シェア、2022年
・抗コリン薬、ベンゾジアゼピン薬、ドーパミン薬、抗けいれん薬、その他

世界の眼瞼痙攣治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の眼瞼痙攣治療薬市場：用途別市場シェア、2022年
・小売薬局、病院薬局、オンライン薬局、その他

世界の眼瞼痙攣治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の眼瞼痙攣治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における眼瞼痙攣治療薬のグローバル売上、2018年-2023年
・主要企業における眼瞼痙攣治療薬のグローバル売上シェア、2022年
・主要企業における眼瞼痙攣治療薬のグローバル販売量、2018年-2023年
・主要企業における眼瞼痙攣治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer Inc.、 Novartis AG、 Sanofi、 Merck and Co.、 Aspen Holdings、 Boston Scientific Corporation、 Ipsen Pharma、 Revance Therapeutics, Inc.、 Merz Pharma、 Allergan

*************************************************************

・調査・分析レポートの概要
眼瞼痙攣治療薬市場の定義
市場セグメント
世界の眼瞼痙攣治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の眼瞼痙攣治療薬市場規模
世界の眼瞼痙攣治療薬市場規模：2022年 VS 2029年
世界の眼瞼痙攣治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの眼瞼痙攣治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の眼瞼痙攣治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗コリン薬、ベンゾジアゼピン薬、ドーパミン薬、抗けいれん薬、その他
眼瞼痙攣治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：小売薬局、病院薬局、オンライン薬局、その他
眼瞼痙攣治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別眼瞼痙攣治療薬市場規模 2022年と2029年
地域別眼瞼痙攣治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer Inc.、 Novartis AG、 Sanofi、 Merck and Co.、 Aspen Holdings、 Boston Scientific Corporation、 Ipsen Pharma、 Revance Therapeutics, Inc.、 Merz Pharma、 Allergan
...

Involuntary Contraction of the muscles of the eyelids causing closure of the lids is observed in Belpharospasm which is a type of dystonia. Frequent blinking and irritation of the eye are few of the symptoms.The global Blepharospasm Therapeutics market is segmented into anticholinergic, benzodiapines, dopaminergic, anticonvulsants and others.
This report aims to provide a comprehensive presentation of the global market for Blepharospasm Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blepharospasm Therapeutic. This report contains market size and forecasts of Blepharospasm Therapeutic in global, including the following market information:
Global Blepharospasm Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Blepharospasm Therapeutic Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Blepharospasm Therapeutic companies in 2022 (%)
The global Blepharospasm Therapeutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anticholinergic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blepharospasm Therapeutic include Pfizer Inc., Novartis AG, Sanofi, Merck and Co., Aspen Holdings, Boston Scientific Corporation, Ipsen Pharma, Revance Therapeutics, Inc. and Merz Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blepharospasm Therapeutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blepharospasm Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blepharospasm Therapeutic Market Segment Percentages, by Type, 2022 (%)
Anticholinergic
Benzodiazepines
Dopaminergic
Anticonvulsants
Others
Global Blepharospasm Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blepharospasm Therapeutic Market Segment Percentages, by Application, 2022 (%)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Others
Global Blepharospasm Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blepharospasm Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blepharospasm Therapeutic revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blepharospasm Therapeutic revenues share in global market, 2022 (%)
Key companies Blepharospasm Therapeutic sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Blepharospasm Therapeutic sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Novartis AG
Sanofi
Merck and Co.
Aspen Holdings
Boston Scientific Corporation
Ipsen Pharma
Revance Therapeutics, Inc.
Merz Pharma
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blepharospasm Therapeutic, market overview.
Chapter 2: Global Blepharospasm Therapeutic market size in revenue and volume.
Chapter 3: Detailed analysis of Blepharospasm Therapeutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blepharospasm Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blepharospasm Therapeutic capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Blepharospasm Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blepharospasm Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blepharospasm Therapeutic Overall Market Size
2.1 Global Blepharospasm Therapeutic Market Size: 2022 VS 2029
2.2 Global Blepharospasm Therapeutic Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Blepharospasm Therapeutic Sales: 2018-2029
3 Company Landscape
3.1 Top Blepharospasm Therapeutic Players in Global Market
3.2 Top Global Blepharospasm Therapeutic Companies Ranked by Revenue
3.3 Global Blepharospasm Therapeutic Revenue by Companies
3.4 Global Blepharospasm Therapeutic Sales by Companies
3.5 Global Blepharospasm Therapeutic Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Blepharospasm Therapeutic Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blepharospasm Therapeutic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blepharospasm Therapeutic Players in Global Market
3.8.1 List of Global Tier 1 Blepharospasm Therapeutic Companies
3.8.2 List of Global Tier 2 and Tier 3 Blepharospasm Therapeutic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Blepharospasm Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Anticholinergic
4.1.3 Benzodiazepines
4.1.4 Dopaminergic
4.1.5 Anticonvulsants
4.1.6 Others
4.2 By Type – Global Blepharospasm Therapeutic Revenue & Forecasts
4.2.1 By Type – Global Blepharospasm Therapeutic Revenue, 2018-2023
4.2.2 By Type – Global Blepharospasm Therapeutic Revenue, 2024-2029
4.2.3 By Type – Global Blepharospasm Therapeutic Revenue Market Share, 2018-2029
4.3 By Type – Global Blepharospasm Therapeutic Sales & Forecasts
4.3.1 By Type – Global Blepharospasm Therapeutic Sales, 2018-2023
4.3.2 By Type – Global Blepharospasm Therapeutic Sales, 2024-2029
4.3.3 By Type – Global Blepharospasm Therapeutic Sales Market Share, 2018-2029
4.4 By Type – Global Blepharospasm Therapeutic Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blepharospasm Therapeutic Market Size, 2022 & 2029
5.1.2 Retail Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application – Global Blepharospasm Therapeutic Revenue & Forecasts
5.2.1 By Application – Global Blepharospasm Therapeutic Revenue, 2018-2023
5.2.2 By Application – Global Blepharospasm Therapeutic Revenue, 2024-2029
5.2.3 By Application – Global Blepharospasm Therapeutic Revenue Market Share, 2018-2029
5.3 By Application – Global Blepharospasm Therapeutic Sales & Forecasts
5.3.1 By Application – Global Blepharospasm Therapeutic Sales, 2018-2023
5.3.2 By Application – Global Blepharospasm Therapeutic Sales, 2024-2029
5.3.3 By Application – Global Blepharospasm Therapeutic Sales Market Share, 2018-2029
5.4 By Application – Global Blepharospasm Therapeutic Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Blepharospasm Therapeutic Market Size, 2022 & 2029
6.2 By Region – Global Blepharospasm Therapeutic Revenue & Forecasts
6.2.1 By Region – Global Blepharospasm Therapeutic Revenue, 2018-2023
6.2.2 By Region – Global Blepharospasm Therapeutic Revenue, 2024-2029
6.2.3 By Region – Global Blepharospasm Therapeutic Revenue Market Share, 2018-2029
6.3 By Region – Global Blepharospasm Therapeutic Sales & Forecasts
6.3.1 By Region – Global Blepharospasm Therapeutic Sales, 2018-2023
6.3.2 By Region – Global Blepharospasm Therapeutic Sales, 2024-2029
6.3.3 By Region – Global Blepharospasm Therapeutic Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Blepharospasm Therapeutic Revenue, 2018-2029
6.4.2 By Country – North America Blepharospasm Therapeutic Sales, 2018-2029
6.4.3 US Blepharospasm Therapeutic Market Size, 2018-2029
6.4.4 Canada Blepharospasm Therapeutic Market Size, 2018-2029
6.4.5 Mexico Blepharospasm Therapeutic Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Blepharospasm Therapeutic Revenue, 2018-2029
6.5.2 By Country – Europe Blepharospasm Therapeutic Sales, 2018-2029
6.5.3 Germany Blepharospasm Therapeutic Market Size, 2018-2029
6.5.4 France Blepharospasm Therapeutic Market Size, 2018-2029
6.5.5 U.K. Blepharospasm Therapeutic Market Size, 2018-2029
6.5.6 Italy Blepharospasm Therapeutic Market Size, 2018-2029
6.5.7 Russia Blepharospasm Therapeutic Market Size, 2018-2029
6.5.8 Nordic Countries Blepharospasm Therapeutic Market Size, 2018-2029
6.5.9 Benelux Blepharospasm Therapeutic Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Blepharospasm Therapeutic Revenue, 2018-2029
6.6.2 By Region – Asia Blepharospasm Therapeutic Sales, 2018-2029
6.6.3 China Blepharospasm Therapeutic Market Size, 2018-2029
6.6.4 Japan Blepharospasm Therapeutic Market Size, 2018-2029
6.6.5 South Korea Blepharospasm Therapeutic Market Size, 2018-2029
6.6.6 Southeast Asia Blepharospasm Therapeutic Market Size, 2018-2029
6.6.7 India Blepharospasm Therapeutic Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Blepharospasm Therapeutic Revenue, 2018-2029
6.7.2 By Country – South America Blepharospasm Therapeutic Sales, 2018-2029
6.7.3 Brazil Blepharospasm Therapeutic Market Size, 2018-2029
6.7.4 Argentina Blepharospasm Therapeutic Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Blepharospasm Therapeutic Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Blepharospasm Therapeutic Sales, 2018-2029
6.8.3 Turkey Blepharospasm Therapeutic Market Size, 2018-2029
6.8.4 Israel Blepharospasm Therapeutic Market Size, 2018-2029
6.8.5 Saudi Arabia Blepharospasm Therapeutic Market Size, 2018-2029
6.8.6 UAE Blepharospasm Therapeutic Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Blepharospasm Therapeutic Major Product Offerings
7.1.4 Pfizer Inc. Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Blepharospasm Therapeutic Major Product Offerings
7.2.4 Novartis AG Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.2.5 Novartis AG Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Blepharospasm Therapeutic Major Product Offerings
7.3.4 Sanofi Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Merck and Co.
7.4.1 Merck and Co. Company Summary
7.4.2 Merck and Co. Business Overview
7.4.3 Merck and Co. Blepharospasm Therapeutic Major Product Offerings
7.4.4 Merck and Co. Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.4.5 Merck and Co. Key News & Latest Developments
7.5 Aspen Holdings
7.5.1 Aspen Holdings Company Summary
7.5.2 Aspen Holdings Business Overview
7.5.3 Aspen Holdings Blepharospasm Therapeutic Major Product Offerings
7.5.4 Aspen Holdings Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.5.5 Aspen Holdings Key News & Latest Developments
7.6 Boston Scientific Corporation
7.6.1 Boston Scientific Corporation Company Summary
7.6.2 Boston Scientific Corporation Business Overview
7.6.3 Boston Scientific Corporation Blepharospasm Therapeutic Major Product Offerings
7.6.4 Boston Scientific Corporation Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.6.5 Boston Scientific Corporation Key News & Latest Developments
7.7 Ipsen Pharma
7.7.1 Ipsen Pharma Company Summary
7.7.2 Ipsen Pharma Business Overview
7.7.3 Ipsen Pharma Blepharospasm Therapeutic Major Product Offerings
7.7.4 Ipsen Pharma Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.7.5 Ipsen Pharma Key News & Latest Developments
7.8 Revance Therapeutics, Inc.
7.8.1 Revance Therapeutics, Inc. Company Summary
7.8.2 Revance Therapeutics, Inc. Business Overview
7.8.3 Revance Therapeutics, Inc. Blepharospasm Therapeutic Major Product Offerings
7.8.4 Revance Therapeutics, Inc. Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.8.5 Revance Therapeutics, Inc. Key News & Latest Developments
7.9 Merz Pharma
7.9.1 Merz Pharma Company Summary
7.9.2 Merz Pharma Business Overview
7.9.3 Merz Pharma Blepharospasm Therapeutic Major Product Offerings
7.9.4 Merz Pharma Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.9.5 Merz Pharma Key News & Latest Developments
7.10 Allergan
7.10.1 Allergan Company Summary
7.10.2 Allergan Business Overview
7.10.3 Allergan Blepharospasm Therapeutic Major Product Offerings
7.10.4 Allergan Blepharospasm Therapeutic Sales and Revenue in Global (2018-2023)
7.10.5 Allergan Key News & Latest Developments
8 Global Blepharospasm Therapeutic Production Capacity, Analysis
8.1 Global Blepharospasm Therapeutic Production Capacity, 2018-2029
8.2 Blepharospasm Therapeutic Production Capacity of Key Manufacturers in Global Market
8.3 Global Blepharospasm Therapeutic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blepharospasm Therapeutic Supply Chain Analysis
10.1 Blepharospasm Therapeutic Industry Value Chain
10.2 Blepharospasm Therapeutic Upstream Market
10.3 Blepharospasm Therapeutic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blepharospasm Therapeutic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Blepharospasm Therapeutic in Global Market
Table 2. Top Blepharospasm Therapeutic Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Blepharospasm Therapeutic Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Blepharospasm Therapeutic Revenue Share by Companies, 2018-2023
Table 5. Global Blepharospasm Therapeutic Sales by Companies, (K Units), 2018-2023
Table 6. Global Blepharospasm Therapeutic Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Blepharospasm Therapeutic Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Blepharospasm Therapeutic Product Type
Table 9. List of Global Tier 1 Blepharospasm Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blepharospasm Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Blepharospasm Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Blepharospasm Therapeutic Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Blepharospasm Therapeutic Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Blepharospasm Therapeutic Sales (K Units), 2018-2023
Table 15. By Type - Global Blepharospasm Therapeutic Sales (K Units), 2024-2029
Table 16. By Application – Global Blepharospasm Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Blepharospasm Therapeutic Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Blepharospasm Therapeutic Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Blepharospasm Therapeutic Sales (K Units), 2018-2023
Table 20. By Application - Global Blepharospasm Therapeutic Sales (K Units), 2024-2029
Table 21. By Region – Global Blepharospasm Therapeutic Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Blepharospasm Therapeutic Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Blepharospasm Therapeutic Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Blepharospasm Therapeutic Sales (K Units), 2018-2023
Table 25. By Region - Global Blepharospasm Therapeutic Sales (K Units), 2024-2029
Table 26. By Country - North America Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Blepharospasm Therapeutic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Blepharospasm Therapeutic Sales, (K Units), 2018-2023
Table 29. By Country - North America Blepharospasm Therapeutic Sales, (K Units), 2024-2029
Table 30. By Country - Europe Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Blepharospasm Therapeutic Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Blepharospasm Therapeutic Sales, (K Units), 2018-2023
Table 33. By Country - Europe Blepharospasm Therapeutic Sales, (K Units), 2024-2029
Table 34. By Region - Asia Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Blepharospasm Therapeutic Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Blepharospasm Therapeutic Sales, (K Units), 2018-2023
Table 37. By Region - Asia Blepharospasm Therapeutic Sales, (K Units), 2024-2029
Table 38. By Country - South America Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Blepharospasm Therapeutic Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Blepharospasm Therapeutic Sales, (K Units), 2018-2023
Table 41. By Country - South America Blepharospasm Therapeutic Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Blepharospasm Therapeutic Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Blepharospasm Therapeutic Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Blepharospasm Therapeutic Sales, (K Units), 2024-2029
Table 46. Pfizer Inc. Company Summary
Table 47. Pfizer Inc. Blepharospasm Therapeutic Product Offerings
Table 48. Pfizer Inc. Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Inc. Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Blepharospasm Therapeutic Product Offerings
Table 52. Novartis AG Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Novartis AG Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Blepharospasm Therapeutic Product Offerings
Table 56. Sanofi Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Merck and Co. Company Summary
Table 59. Merck and Co. Blepharospasm Therapeutic Product Offerings
Table 60. Merck and Co. Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Merck and Co. Key News & Latest Developments
Table 62. Aspen Holdings Company Summary
Table 63. Aspen Holdings Blepharospasm Therapeutic Product Offerings
Table 64. Aspen Holdings Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Aspen Holdings Key News & Latest Developments
Table 66. Boston Scientific Corporation Company Summary
Table 67. Boston Scientific Corporation Blepharospasm Therapeutic Product Offerings
Table 68. Boston Scientific Corporation Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Boston Scientific Corporation Key News & Latest Developments
Table 70. Ipsen Pharma Company Summary
Table 71. Ipsen Pharma Blepharospasm Therapeutic Product Offerings
Table 72. Ipsen Pharma Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Ipsen Pharma Key News & Latest Developments
Table 74. Revance Therapeutics, Inc. Company Summary
Table 75. Revance Therapeutics, Inc. Blepharospasm Therapeutic Product Offerings
Table 76. Revance Therapeutics, Inc. Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Revance Therapeutics, Inc. Key News & Latest Developments
Table 78. Merz Pharma Company Summary
Table 79. Merz Pharma Blepharospasm Therapeutic Product Offerings
Table 80. Merz Pharma Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Merz Pharma Key News & Latest Developments
Table 82. Allergan Company Summary
Table 83. Allergan Blepharospasm Therapeutic Product Offerings
Table 84. Allergan Blepharospasm Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Allergan Key News & Latest Developments
Table 86. Blepharospasm Therapeutic Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Blepharospasm Therapeutic Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Blepharospasm Therapeutic Production by Region, 2018-2023 (K Units)
Table 89. Global Blepharospasm Therapeutic Production by Region, 2024-2029 (K Units)
Table 90. Blepharospasm Therapeutic Market Opportunities & Trends in Global Market
Table 91. Blepharospasm Therapeutic Market Drivers in Global Market
Table 92. Blepharospasm Therapeutic Market Restraints in Global Market
Table 93. Blepharospasm Therapeutic Raw Materials
Table 94. Blepharospasm Therapeutic Raw Materials Suppliers in Global Market
Table 95. Typical Blepharospasm Therapeutic Downstream
Table 96. Blepharospasm Therapeutic Downstream Clients in Global Market
Table 97. Blepharospasm Therapeutic Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Blepharospasm Therapeutic Segment by Type in 2022
Figure 2. Blepharospasm Therapeutic Segment by Application in 2022
Figure 3. Global Blepharospasm Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Blepharospasm Therapeutic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Blepharospasm Therapeutic Revenue, 2018-2029 (US$, Mn)
Figure 7. Blepharospasm Therapeutic Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Blepharospasm Therapeutic Revenue in 2022
Figure 9. By Type - Global Blepharospasm Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Blepharospasm Therapeutic Revenue Market Share, 2018-2029
Figure 11. By Type - Global Blepharospasm Therapeutic Sales Market Share, 2018-2029
Figure 12. By Type - Global Blepharospasm Therapeutic Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Blepharospasm Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Blepharospasm Therapeutic Revenue Market Share, 2018-2029
Figure 15. By Application - Global Blepharospasm Therapeutic Sales Market Share, 2018-2029
Figure 16. By Application - Global Blepharospasm Therapeutic Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Blepharospasm Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Blepharospasm Therapeutic Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Blepharospasm Therapeutic Revenue Market Share, 2018-2029
Figure 20. By Region - Global Blepharospasm Therapeutic Sales Market Share, 2018-2029
Figure 21. By Country - North America Blepharospasm Therapeutic Revenue Market Share, 2018-2029
Figure 22. By Country - North America Blepharospasm Therapeutic Sales Market Share, 2018-2029
Figure 23. US Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Blepharospasm Therapeutic Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Blepharospasm Therapeutic Sales Market Share, 2018-2029
Figure 28. Germany Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 29. France Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Blepharospasm Therapeutic Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Blepharospasm Therapeutic Sales Market Share, 2018-2029
Figure 37. China Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 41. India Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Blepharospasm Therapeutic Revenue Market Share, 2018-2029
Figure 43. By Country - South America Blepharospasm Therapeutic Sales Market Share, 2018-2029
Figure 44. Brazil Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Blepharospasm Therapeutic Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Blepharospasm Therapeutic Sales Market Share, 2018-2029
Figure 48. Turkey Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Blepharospasm Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 52. Global Blepharospasm Therapeutic Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Blepharospasm Therapeutic by Region, 2022 VS 2029
Figure 54. Blepharospasm Therapeutic Industry Value Chain
Figure 55. Marketing Channels

※参考情報

眼瞼痙攣（がんけんけいれん）とは、まぶたの筋肉が不随意に収縮し、まぶたが閉じてしまう状態を指します。この症状は、しばしば痛みや不快感を伴い、視界を妨げることもあります。眼瞼痙攣は、主に中高年の女性に多く見られ、生活の質に大きな影響を及ぼすことがあります。それに対する治療薬は、症状を緩和し、患者の生活を改善するために重要な役割を果たします。

眼瞼痙攣治療薬の主な目的は、筋肉の不随意な収縮を抑えることです。これにより、まぶたの開閉に関する制御が改善され、患者は日常生活をより快適に過ごすことができます。治療薬にはいくつかの種類があり、それぞれ異なるメカニズムで作用します。

眼瞼痙攣の治療において、最も一般的に用いられる薬剤はボツリヌストキシン（ボトックス）です。ボツリヌストキシンは神経伝達物質の放出を抑制することで筋肉の収縮を防ぎます。患者のまぶたに注射されることで、数ヶ月間効果が持続し、多くの患者にとっては症状の改善が見られます。ボツリヌストキシンは、安全性が高く、比較的少ない副作用であるため、第一選択の治療薬とされています。

また、経口薬としては抗けいれん薬や抗うつ薬が使用されることもあります。例えば、ジアゼパムやクロナゼパムなどのベンゾジアゼピン系薬剤は、筋肉の緊張を和らげる効果があります。しかし、これらの薬剤は副作用が出ることが多く、長期間の使用が難しい場合があります。そのため、主に補助的な治療として位置付けられています。

眼瞼痙攣治療薬のもう一つのアプローチは、神経調節療法です。これは、神経の機能を調整し、痙攣を抑える技術であり、例えば経皮的経頭蓋磁気刺激（TMS）などが含まれます。TMSは、磁場を使用して脳の特定の領域に刺激を与えることで、神経の活動を調整し、症状の軽減を試みるものです。この治療法は、比較的新しい方法であり、今後の研究によってさらに確立されていくことが期待されます。

眼瞼痙攣の治療には、薬物療法だけでなく、リハビリテーションや生活習慣の改善も重要です。ストレス管理や十分な睡眠、バランスの取れた食事は、症状の悪化を防ぐために有効です。また、眼瞼プラトー運動やマッサージなどのリハビリテーションも、筋肉の緊張を和らげる助けとなるでしょう。

治療薬の選択は、患者の症状や生活環境に応じて慎重に行われるべきです。効果的な治療法を見つけるためには、医師との十分なコミュニケーションが不可欠です。患者の個々の症状や生活スタイルに応じたアプローチを組み合わせることで、最適な治療が実現されるでしょう。

近年では、眼瞼痙攣の治療において新たな研究が進められており、より効果的な治療薬や治療法の開発が期待されています。新しい薬剤が開発されることで、従来の選択肢では効果が薄い患者にも希望がもたらされることでしょう。また、遺伝子治療や幹細胞治療など、新しい技術が眼瞼痙攣の治療に導入される可能性も考えられています。

眼瞼痙攣という症状は、ただ単に身体的な問題だけではなく、精神的なストレスや社会的な影響も大きく絡んでいます。治療にあたる際には、身体の健康だけでなく、心理的なサポートや社会復帰への配慮も重要です。患者自身が抱える不安や悩みを理解し、支えることで、より良い治療成果を上げることが可能となります。

総じて、眼瞼痙攣治療薬は、多様なアプローチを通じて患者の生活の質を向上させるための重要な手段です。今後の研究と技術の進歩により、さらに多くの患者に効果的な治療が提供されることが期待されます。こうした取り組みは、眼瞼痙攣に苦しむ人々にとって、希望の光となることでしょう。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 眼瞼痙攣治療薬の世界市場見通し2023年-2029年(Blepharospasm Therapeutic Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 生物学的治療薬の世界市場見通し2023年-2029年
  • ジカウイルス治療薬の世界市場見通し2023年-2029年
  • アデノシンデアミナーゼ欠損症療法の世界市場見通し2023年-2029年
  • 腫瘍治療薬の世界市場見通し2023年-2029年
  • 脊髄損傷治療薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆